Decreasing Cardiovascular Risk for Patients with Persistent
Hypercholesterolemia – An Animated Whiteboard View

View Activity

FACULTY

Christie M. Ballantyne, MD
Professor of Medicine, Molecular and Human Genetics
Chief of Cardiology and Cardiovascular Research
Director, The Maria and Alando J. Ballantyne, MD, Atherosclerosis Clinical Research Laboratory
Baylor College of Medicine
Houston, Texas

PROGRAM OVERVIEW

This enduring activity is focused on the management and care of patients with hypercholesterolemia who are at high risk for cardiovascular disease.

TARGET AUDIENCE

This CME initiative is designed to meet the needs of lipidologists, cardiologists, endocrinologists, and other healthcare professionals involved in the management of patients at high risk for cardiovascular disease (CVD) due to hypercholesterolemia.

LEARNING OBJECTIVES

Upon completion of the program, attendees should be able to:

  • Discuss how lowering LDL-C levels can reduce CVD risk in patients with persistently elevated cholesterol levels
  • Review clinical trial data on nonstatin LDL-C–lowering agents in patients with persistently elevated LDL-C levels and evidence regarding their positioning in treatment regimens
  • Describe best practices for identifying and managing patients with persistently elevated LDL-C levels and at high risk for CVD

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the management and care of patients with hypercholesterolemia who are at high risk for cardiovascular disease.

Credits: 1.0 ANCC Contact Hour

CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education for RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Christie Ballantyne, MD, receives grant/research support paid directly to the institution from Abbott Diagnostic, Akcea, Amgen, Esperion, Novartis, Regeneron, Roche Diagnostic, Sanofi-Synthelabo, NIH, ADA, AHA; receives consultant fees from Abbott Diagnostic, Akcea, Amarin, Amgen, Astra Zeneca, Boehringer Ingelheim, Denka Seiken, Esperion, Intercept, Janssen, Matinas BioPharma Inc, Merck, Novartis, Novo Nordisk, Regeneron, Roche Diagnostic, Sanofi-Synthelabo. He also has a provisional patent: “Biomarkers to Improve Prediction of Heart Failure Risk” (patent no. 61721475) filed by Baylor College of Medicine and Roche

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP Educational Development for Med Learning Group has nothing to disclose.
Felecia Beachum, Program Manager for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes for Med Learning Group has nothing to disclose.
Brianna Hanson, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures.
2. Participate in the online activity.
3. Submit the evaluation form to Med Learning Group.

You will receive your certification as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at; info@medlearninggroup.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://medlearninggroup.com/privacy‐policy/

RELEASE DATE: September 24, 2019

EXPIRATION DATE: September 24, 2020

View Activity

Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.